The Effect of rTMS to the Prefrontal Cortex in Alcohol Use Disorder

Last updated: May 9, 2025
Sponsor: New York State Psychiatric Institute
Overall Status: Suspended

Phase

N/A

Condition

Alcohol Use Disorder

Addictions

Alcohol Dependence

Treatment

active rTMS

sham rTMS

Inpatient admission

Clinical Study ID

NCT03809286
7691
1K23AA028295
5R21AA026049
  • Ages 22-55
  • All Genders

Study Summary

The goal of this study is to investigate a treatment approach for alcohol use disorder (AUD) using a novel form of brain stimulation called deep repetitive transcranial magnetic stimulation (rTMS). The investigators will be targeting frontal regions of the brain that are important for memory and decision making. These brain regions have been shown to be impaired in patients with AUD. Previous studies have mostly used rTMS to a different frontal brain region that is not as deep. These studies have shown that rTMS can reduce craving for alcohol, but there is a lack of research showing that rTMS impacts alcohol consumption.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Current moderate to severe alcohol use disorder, per DSM-5

  2. Use of alcohol which parallels or exceeds the amount alcohol that will beadministered in this study (1 drinking episode per week raising BAL to 0.03 g/dl -approximately 2 drinks within an hour).

  3. Age 22-55

  4. Able to give informed consent, and comply with study procedures

  5. Medically healthy, with the absence of current or past medical or neurologicalillnesses (including glaucoma, increased intracranial pressure, liver disease,cardiac disease, or seizure disorders)

Exclusion

Exclusion Criteria:

  1. Has a contraindication to MRI, such as magnetically reactive implants, whichincludes metal in head except in mouth (cochlear implant, implanted brainstimulators, aneurysm clips), cardiac pacemakers, implanted neurostimulators andmedication pumps, and intracardiac lines.

  2. Substance use disorder with substances other than alcohol or nicotine. The currentuse of sedative-hypnotics or opiates will be exclusionary

  3. Meets DSM-5 criteria for other psychiatric illness, such as major depression, thatwould interfere with participation.

  4. History of seizures of any type

  5. A family history of epilepsy

  6. Taking psychotropic medication that would affect resting motor threshold (such asanticonvulsants) or increase risk of seizure (especially tricyclic antidepressantsof neuroleptics)

  7. Current suicide risk or a history of suicide attempt within the past 2 years

  8. Have unstable physical disorders, including those that are previously undiagnosed,untreated, inadequately treated, or active to an extent which might makeparticipation hazardous. For example, hypertension (a resting blood pressure > 140/90), heart failure, a recent history of myocardial infarction, previous stroke,brain lesions, any history of seizures under any circumstances or low hemoglobin.

  9. Currently pregnant

  10. History of severe alcohol withdrawal requiring medical care, such as withdrawalseizures, delirium tremens, withdrawal necessitating medical detoxification.

  11. A desire to pursue standard treatment for AUD, such as a rehabilitation program orFDA approved medications for AUD

Study Design

Total Participants: 44
Treatment Group(s): 3
Primary Treatment: active rTMS
Phase:
Study Start date:
June 24, 2019
Estimated Completion Date:
December 30, 2025

Study Description

This study aims to examine the effect of rTMS on alcohol drinking behavior in an observed laboratory setting. Participants with AUD will be recruited and admitted to the inpatient unit for the whole study. After a brief detoxification period, they will receive 3 weeks of rTMS while in the research unit. Before and after the 3 weeks of stimulation, participants will participate in a decision-making experiment where they can choose to have an alcoholic drink or the equivalent amount of money that the drink would cost (alcohol self-administration sessions). The investigators will examine their response to alcohol, as well as their performance on tasks that relate to impulsivity and memory. Participants will also undergo an MRI scan (with spectroscopy) before and after the stimulation period to look at changes in the medial prefrontal cortex of the brain. Participants will then meet with a study physician for 6 weeks after the study for assessments of alcohol use and medical management sessions.

Connect with a study center

  • New York State Psychiatric Institute

    New York, New York 10032
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.